By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Shares of Affymetrix's stock rose as much as 13 percent today following the announcement on Wednesday that a new president and CEO would be leading the company starting July 1.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.
At Nature, John Wilbanks and Eric Topol call for openness in health data.
Law.com predicts that genomic and genetic testing will become common in toxic tort cases.
A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.